Shenzhen Hepalink Pharmaceutical Group has filed a patent for novel compositions of berberine combined with pharmacologically active organic acids. The patent claims that these compositions can be used to treat various diseases including diabetes, dyslipidemia, obesity, neurodegenerative diseases, inflammation, and cancer. The composition includes berberine or its derivative, pharmacologically active organic acids, and optionally a pharmaceutically acceptable excipient. GlobalData’s report on Shenzhen Hepalink Pharmaceutical Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Shenzhen Hepalink Pharmaceutical Group, Transgenic murine models was a key innovation area identified from patents. Shenzhen Hepalink Pharmaceutical Group's grant share as of September 2023 was 48%. Grant share is based on the ratio of number of grants to total number of patents.
Composition of berberine and organic acids for treating diseases
A recently filed patent (Publication Number: US20230295151A1) describes a composition and method for treating various diseases and disorders. The composition includes berberine or a derivative or analog thereof, along with one or more pharmacologically active organic acids. Optionally, a pharmaceutically acceptable excipient, carrier, or diluent may be included. When administered to a subject, the combination of berberine and pharmacologically active organic acids is effective in treating, preventing, or reducing diseases and disorders such as metabolic disorders, atherosclerosis, heart diseases, neurodegenerative diseases, liver diseases, sarcopenia, muscle atrophy, inflammation, and cancer, or related diseases or disorders in mammals, including humans.
Furthermore, the patent also discloses a method for treating, reducing, or preventing metabolic disorders, heart diseases, neurodegenerative diseases, and liver diseases. The method involves administering a pharmaceutical composition to a subject in need thereof. The composition includes berberine or a derivative or analog thereof, along with one or more pharmacologically active organic acids, in a therapeutically effective amount. Optionally, a pharmaceutically acceptable excipient, carrier, or diluent may be included.
Additionally, the patent describes a kit that includes various agents and instructions for administering them to patients with or at risk of having diseases or disorders such as metabolic disorders, atherosclerosis, heart diseases, sarcopenia, muscle atrophy, neurodegenerative diseases, liver diseases, and cancer. The kit includes a first agent of berberine or a derivative or analog thereof, one or more second agents selected from pharmaceutically active organic acids or natural extracts containing such acids, and one or more third agents selected from a group of vitamins and other compounds. The instructions guide the administration of these agents to the patients.
In summary, this patent presents a composition and method for treating a wide range of diseases and disorders using a combination of berberine or its derivatives or analogs, along with pharmacologically active organic acids. The patent also introduces a kit that includes various agents and instructions for administering them to patients with specific diseases or disorders. These innovations have the potential to provide new treatment options for individuals suffering from metabolic disorders, heart diseases, neurodegenerative diseases, liver diseases, and other related conditions.
To know more about GlobalData’s detailed insights on Shenzhen Hepalink Pharmaceutical Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
